ð ãå¿ èŠãPHQ-9ãšDSM-5-TRã®å¯Ÿå¿é¢ä¿ããããïŒãã€ç 蚺æãåçã«å¹çåããå®è·µçã¬ã€ã
ââââââââââââââââââââââââââ
ð¯ ãã®èšäºã®å 容
PHQ-9ã䜿ã£ãŠããããã©ãDSM-5-TRã®èšºæåºæºãšã©ã察å¿ããŠããã®ãããããªã...ããæ©ãã§ããç ä¿®å»ã®æ¹ã¯å€ãã®ã§ã¯ãªãã§ããããïŒå®ã¯ãPHQ-9ã¯DSM-5-TRã®9ã€ã®èšºæåºæºã«1察1ã§å¯Ÿå¿ããããã«èšèšãããæ§é å颿¥ããŒã«ã§ãããã®å¯Ÿå¿é¢ä¿ãçè§£ããã°ããã€ç ã®èšºæãæ Œæ®µã«å¹ççã«ãªããŸãããã®èšäºã§ã¯ãããã©ã³æå°å»ãšç ä¿®å»ã®å¯Ÿè©±åœ¢åŒã§ãPHQ-9ãšDSM-5-TRã®å®å šå¯Ÿå¿ã解説ããå¿ãã倿¥ã§ãå®è·µã§ãã3ã¹ãããã®èšºæããã»ã¹ã玹ä»ããŸããææ¥ããã®èšåºã«å³æŽ»ãããå 容ã§ãã
æšå¥šããã·ã¥ã¿ã°:
#å»åŠæè² #ç ä¿®å» #èšåºå»åŠ #粟ç¥ç§ #ãã€ç
#PHQ -9 #DSM -5-TR #å»åž«åã
ââââââââââââââââââââââââââ
ãã»ã¯ã·ã§ã³1: å°å ¥ã
Dr. SAP (ç ä¿®å»): ãå çããã£ãã®æ£è ããã§PHQ-9ã宿œãããã§ããã©ãã¹ã³ã¢ã¯15ç¹ã§ãããã§ãããããDSM-5-TRã®èšºæåºæºãšã©ã察å¿ãããã°ããã®ããæ£çŽããããããªããŠ...ã
Dr. MK (æå°å»): ããã質åã ããå®ã¯ãPHQ-9ãšDSM-5-TRã®å¯Ÿå¿é¢ä¿ãçè§£ãããšããã€ç ã®èšºæãåçã«å¹çåãããã ãå€ãã®ç ä¿®å»ããPHQ-9ã¯åãªãã¹ã¯ãªãŒãã³ã°ããŒã«ã ãšæã£ãŠãããã©ãå®ã¯ãã£ãšæ·±ãèšèšææ³ããããã ããã
Dr. SAP: ãèšèšææ³...ïŒãšãããšïŒã
Dr. MK: ãPHQ-9ã¯ãDr. Robert L. Spitzerãã«ãã£ãŠéçºããããã ãã©ãå®ã¯DSM-IVïŒçŸDSM-5-TRïŒã®9ã€ã®èšºæåºæºã«å®å šå¯Ÿå¿ããããã«èšèšãããŠãããã ãã€ãŸããPHQ-9ã®å質åããDSM-5-TRã®å蚺æåºæºãš1察1ã§å¯Ÿå¿ããŠããããããçè§£ããã°ãPHQ-9ã®çµæãããèªåçã«DSM-5-TRã®èšºæåºæºãè©äŸ¡ã§ããããã«ãªããã ããã
Dr. SAP: ããªãã»ã©...ã€ãŸããPHQ-9ã䜿ãã°ãDSM-5-TRã®èšºæåºæºããã§ãã¯ããæéãçãããšããããšã§ããïŒã
Dr. MK: ããŸãã«ãã®éãããã ããå®å šã«å¯Ÿå¿ããŠããé ç®ãšãéšå察å¿ã®é ç®ãããããããããæŒãããŠãããªããšãããªããããšãPHQ-9ã®æåã®2åãã€ãŸãPHQ-2ã«ãç¹å¥ãªæå³ããããã ããããããããšãèšåºã§ã®äœ¿ãæ¹ãäžæ°ã«å¹çåããããã
ââââââââââââââââââââââââââ
ð¡ 仿¥ã®ããŒã
PHQ-9ã¯DSM-5-TRã®9ã€ã®èšºæåºæºã«1察1ã§å¯Ÿå¿ããããã«èšèšãããæ§é å颿¥ããŒã«ããã®å¯Ÿå¿é¢ä¿ãçè§£ããPHQ-2âPHQ-9âDSM-5-TR蚺æåºæºã®3ã¹ãããã§å¹ççã«èšºæãã
ââââââââââââââââââââââââââ
ð¯ ã»ã¯ã·ã§ã³2: PHQ-9ã®èšèšææ³ãšPHQ-2ã®ç¹å¥ãªæå³ïŒGolden ruleãçè§£ããïŒ
Dr. SAP: ãPHQ-9ãšDSM-5-TRã®å¯Ÿå¿é¢ä¿ãæããŠãã ãããç¹ã«ãå®å šå¯Ÿå¿ãšéšå察å¿ã®éããç¥ãããã§ããã
Dr. MK: ããã質åã ãããŸãã察å¿é¢ä¿ãæŽçãããšãããªãïŒ
å®å
šå¯Ÿå¿ïŒ7é
ç®ïŒïŒ
â æãã€æ°å â PHQ-9 Q2
â¡ã¢ã³ããã㢠â PHQ-9 Q1
â¢äžç /éç â PHQ-9 Q3
â€ç²åŽ/ãšãã«ã®ãŒäœäž â PHQ-9 Q4
â¥ç²Ÿç¥éåçŠç¥/å¶æ¢ â PHQ-9 Q8
â§ç¡äŸ¡å€æ/éå°ãªçœªæªæ â PHQ-9 Q6
âšèªæ®ºå¿µæ
® â PHQ-9 Q9
éšå察å¿ïŒ2é
ç®ïŒïŒ
â£äœéå€å/飿¬²å€å â PHQ-9 Q5ïŒé£æ¬²ã®ã¿ãäœéã¯å¥é確èªïŒ
âŠéäžåäœäž/決æå°é£ â PHQ-9 Q7ïŒéäžåã®ã¿ã決æå°é£ã¯å¥é確èªïŒã
Dr. SAP: ãéšå察å¿ã®é ç®ããããã§ãããã©ã察åŠããã°ããã§ããïŒã
Dr. MK: ãèšåºçã«ã¯ãPHQ-9 Q5ïŒé£æ¬²ïŒãQ7ïŒéäžåïŒãéœæ§ã ã£ãããäœéå€åãæ±ºæå°é£ãå¥é確èªããå¿ èŠãããããã§ããã»ãšãã©ã®å ŽåãPHQ-9ã ãã§èšºæåºæºãæºãããã©ããã¯å€æã§ãããã ãã
Dr. SAP: ãPHQ-2ã«ã€ããŠæããŠãã ããããªãæåã®2åã ãã§ã¹ã¯ãªãŒãã³ã°ã§ãããã§ããïŒã
Dr. MK: ãå®ã¯ãããããPHQ-9ã®èšèšã®"Golden rule"ãªãã ãPHQ-2ã¯ãPHQ-9ã®Q1ãšQ2ãã€ãŸãâ ã¢ã³ãããã¢ãšâ¡æãã€æ°åã«å¯Ÿå¿ããŠããããããŠãDSM-5-TRã®èšºæåºæºã§ã¯ã9ã€ã®çç¶ã®ãã¡å°ãªããšã1ã€ã¯â ãŸãã¯â¡ãå¿ é ãªãã ãã
Dr. SAP: ãã€ãŸããâ ãšâ¡ãäž¡æ¹é°æ§ãªãã蚺æåºæºãæºãããªããšããããšã§ãããã
Dr. MK: ããã®éããã ãããPHQ-2ã§å¹ççã«ã¹ã¯ãªãŒãã³ã°ã§ãããã ããæåºŠ86%ãç¹ç°åºŠ78%ãšããããŒã¿ããã£ãŠãã«ãããªãã¯2ç¹ä»¥äžãã¹ã³ã¢ã2以äžãªããæ®ãã®PHQ-9ã宿œããããšããæµãã«ãªãããã
Dr. SAP: ã30ç§ã§ã¹ã¯ãªãŒãã³ã°ã§ãããšããããšã§ãããã§ãããªãâ ãšâ¡ãå¿ é ãªãã§ããïŒã
Dr. MK: ããã質åã ããããã¯ããã€ç ã®æ¬è³ªçãªçç¶ã ãããªãã ãæãã€æ°åãšèå³ã»åã³ã®åªå€±ã¯ããã€ç ã®æ žå¿ã衚ãçç¶ã§ãã©ã¡ããäžæ¹ã§ãããã°ããã€ç ã®å¯èœæ§ãé«ããªããéã«ããã®2ã€ãäž¡æ¹ãªããã°ãä»ã®çç¶ããã£ãŠãããã€ç ã®èšºæã¯æ éã«ãªãã¹ããªãã ããã
ââââââââââââââââââââââââââ
ð PHQ-2ãšPHQ-9ã®èšèšææ³ãŸãšã
â PHQ-2 = DSM-5-TRã®å¿ é çç¶2ã€ïŒâ æãã€æ°å + â¡ã¢ã³ãããã¢ïŒ
â PHQ-2ã§äž¡æ¹é°æ§ãªã蚺æåºæºãæºãããªãâ ã¹ã¯ãªãŒãã³ã°ã«æé©ïŒæåºŠ86%ãç¹ç°åºŠ78%ïŒ
â PHQ-9ã¯DSM-5-TRã®9é ç®ã«1察1察å¿ïŒå®å šå¯Ÿå¿7é ç®ãéšå察å¿2é ç®ïŒ
â éšå察å¿é ç®ïŒâ£äœéå€åãâŠæ±ºæå°é£ïŒã¯ãPHQ-9éœæ§æã¯å¥é確èªãå¿ èŠ
â ã«ãããªãå€: PHQ-2â¥2ç¹ã§éœæ§ â PHQ-9宿œãž
ââââââââââââââââââââââââââ
ð¯ ã»ã¯ã·ã§ã³3: å®å šå¯Ÿå¿ãšéšå察å¿ã®éãïŒBlind spotãèŠéããªïŒ
Dr. SAP: ãå®å šå¯Ÿå¿ãšéšå察å¿ã®éãããããå°ã詳ããæããŠãã ãããç¹ã«ãèšåºã§èŠèœãšãããããã€ã³ãã¯ãããŸããïŒã
Dr. MK: ãéèŠãªãã€ã³ãã ãããŸããå®å šå¯Ÿå¿ã®é ç®ã«ã€ããŠã¯ãPHQ-9ã®çµæããã®ãŸãŸDSM-5-TRã®èšºæåºæºãšããŠäœ¿ãããã§ããéšå察å¿ã®2é ç®ã¯èŠæ³šæãªãã ããããã蚺æã®"Blind spotïŒç²ç¹ïŒ"ã«ãªãããããã
Dr. SAP: ãBlind spot...å ·äœçã«ã¯ã©ãããããšã§ããïŒã
Dr. MK: ãäŸãã°ãPHQ-9 Q5ïŒé£æ¬²ïŒãéœæ§ã§ãæ£è ãããã飿¬²ããªãããšçãããšãããã§ããDSM-5-TRã®èšºæåºæºã§ã¯ãã飿¬²æžå°ãã ããããªããŠãã1ã¶æã§äœéã®5%以äžã®å€åããå«ãŸãããã ãã€ãŸãã飿¬²ã¯èœã¡ãŠãããã©ãäœéå€åããŸã ãªãããšããæ©æã®ç¶æ ã§ã¯ãPHQ-9ã¯éœæ§ã ãã©ãDSM-5-TRã®åºæºâ£ã¯æºãããªãå¯èœæ§ããããéã«ã飿¬²ã¯ãããã©ãäœããã®çç±ã§äœéãæžã£ãŠããå Žåããããã
Dr. SAP: ããªãã»ã©ãã€ãŸããPHQ-9 Q5ãéœæ§ãªããäœéå€åã確èªããå¿ èŠããããšããããšã§ãããã
Dr. MK: ããã®éããåæ§ã«ãPHQ-9 Q7ïŒéäžåïŒãéœæ§ã§ããDSM-5-TRã®åºæºâŠã¯ãéäžåäœäžãŸãã¯æ±ºæå°é£ãã ãããéäžåã¯ä¿ãããŠãããã©ã決æå°é£ãããæ£è ããããããç¹ã«é«éœ¢è ããè€éãªç¶æ³ã«çœ®ãããŠããæ£è ããã§ã¯ã決æå°é£ã ããçç¶ãšããŠåºãããšããããã ããã
Dr. SAP: ãã§ã¯ãéšå察å¿ã®é ç®ã«ã€ããŠã¯ãPHQ-9ã§éœæ§ã ã£ãããå¿ ã远å 確èªãå¿ èŠãšããããšã§ããïŒã
Dr. MK: ãèšåºçã«ã¯ãããèããæ¹ãå®å šã ããã§ããå®éã«ã¯ãPHQ-9ã§5é ç®ä»¥äžéœæ§ã§ããã°ãéšå察å¿ã®é ç®ã远å 確èªããªããŠãã蚺æåºæºãæºããããšã¯å€ãããªããªããä»ã®é ç®ã§åºæºãæºãããããã§ããã®ãªã®ãª5é ç®ã®å Žåã¯ãéšå察å¿ã®é ç®ããã¡ããšè©äŸ¡ããå¿ èŠããããã ãã
Dr. SAP: ã粟ç¥éåçç¶ïŒâ¥ïŒã«ã€ããŠãDSM-5-TRã§ã¯ãä»è ã芳å¯å¯èœããšæžããŠãããŸãããPHQ-9ã§ã¯ã©ãã§ããïŒã
Dr. MK: ããããšããã«æ°ã¥ããããå®ã¯ãPHQ-9 Q8ã§ã¯ããä»äººãæ°ã¥ãã»ã©ïŒother people could have noticedïŒããšãã衚çŸã䜿ã£ãŠãããã€ãŸããPHQ-9ããä»è ã芳å¯å¯èœããšããåºæºãæºããããã«èšèšãããŠãããã ãããã¯ãæ£è ããèªèº«ã®äž»èгã ãã§ãªãã客芳çãªèгå¯ãéèŠã ãšããèãæ¹ããæ¥ãŠããããã
ââââââââââââââââââââââââââ
ð Pearl (èšåºã®ç¥æµ)
éšå察å¿é ç®ã®"Blind spot"ãã§ãã¯ãªã¹ã
PHQ-9 Q5ïŒé£æ¬²ïŒãéœæ§ â äœéå€åïŒ1ã¶æã§5%以äžïŒã远å 確èª
PHQ-9 Q7ïŒéäžåïŒãéœæ§ â æ±ºæå°é£ã远å 確èªïŒãç°¡åãªæ±ºæã§ãè¿·ããŸããïŒãïŒ
ç¹ã«ãPHQ-9ã¹ã³ã¢ãã®ãªã®ãª5é ç®ïŒ5-6ç¹ïŒã®å Žåã¯ãéšå察å¿é ç®ãäžå¯§ã«è©äŸ¡ïŒ
ââââââââââââââââââââââââââ
ââââââââââââââââââââââââââ
â ïž Pitfall (èœãšã穎)
PHQ-9ã®ã¹ã³ã¢ã ãã§ã¯èšºæã§ããªãïŒ
DSM-5-TRã®èšºæåºæºBã§ã¯ããèšåºçã«èããèŠçãŸãã¯æ©èœé害ããå¿ èŠãPHQ-9ã®æåŸã®è³ªåã§æ©èœé害ãè©äŸ¡ããããšãå¿ããã«ãã¹ã³ã¢ãé«ããŠããæ©èœé害ããªããã°ã蚺æã¯æ éã«ãªãã¹ãã
ââââââââââââââââââââââââââ
ð¯ ã»ã¯ã·ã§ã³4: èšåºã§ã®å®è·µçæŽ»çšæ³ïŒ3ã¹ãããã®èšºæããã»ã¹ïŒ
Dr. SAP: ãå®éã®å€æ¥ã§ã¯ãã©ã®ããã«äœ¿ãã°å¹ççã§ããïŒå¿ãã倿¥ã§ãå®è·µã§ããæ¹æ³ãæããŠãã ãããã
Dr. MK: ããã質åã ããå®ã¯ã3ã¹ãããã®èšºæããã»ã¹ã䜿ãã°ãå¿ãã倿¥ã§ãå¹ççã«èšºæã§ãããã ãã
Dr. SAP: ã3ã¹ããã...å ·äœçã«ã¯ïŒã
Dr. MK: ããã¹ããã1ãPHQ-2ã§ã¹ã¯ãªãŒãã³ã°ïŒ30ç§ïŒ
ãéå»2é±éã§...ã
Q1: ç©äºã«å¯ŸããŠã»ãšãã©èå³ããªãããŸãã¯æ¥œãããªãïŒ
Q2: æ°åãèœã¡èŸŒããæãã€ã«ãªãããŸãã¯çµ¶æçãªæ°æã¡ã«ãªãïŒ
ã©ã¡ããããã¯ããïŒæ°æ¥ä»¥äžïŒãªã â ã¹ããã2ãž
ãã¹ããã2ãPHQ-9å šäœã宿œïŒ3-5åïŒ
â ã¹ã³ã¢å + æ©èœé害ã®ç¢ºèªïŒæåŸã®è³ªåïŒ
ã¹ã³ã¢â¥10ç¹ãªã â ã¹ããã3ãž
ãã¹ããã3ãDSM-5-TR蚺æåºæºã§ç¢ºèª
å®ã¯ãPHQ-9ã宿œããŠããã°ããã§ã«ã»ãšãã©ç¢ºèªæžã¿ãªãã ïŒ
5çç¶ä»¥äžïŒïŒPHQ-9ã§èªåçã«ç¢ºèªæžã¿ïŒ
â ãŸãã¯â¡å«ãïŒïŒQ1ãQ2ãéœæ§ãªãæºããïŒ
åã2é±éïŒïŒPHQ-9ã®è³ªåæã«å«ãŸããïŒ
æ©èœé害ïŒïŒPHQ-9æåŸã®è³ªåã§ç¢ºèªïŒ
äºæ¬¡çåå é€å€ïŒå極æ§é害ãè¬å€ãå»åŠçç¶æ ïŒ
ããã§ã蚺æåºæºã®ç¢ºèªãäžæ°ã«å¹çåãããã ããã
Dr. SAP: ããªãã»ã©ãPHQ-9ã宿œããŠããã°ãDSM-5-TRã®èšºæåºæºã¯ã»ãšãã©ç¢ºèªæžã¿ãšããããšã§ãããã§ããæ©èœé害ã®è©äŸ¡ã«ã€ããŠãããå°ã詳ããæããŠãã ãããã
Dr. MK: ãPHQ-9ã®æåŸã«ã¯ãæ©èœé害ãè©äŸ¡ãã質åããããã ïŒ
ããããã®åé¡ãããªãã®ä»äºãå®¶äºãä»äººãšã®é¢ä¿ã«ã©ã®çšåºŠæ¯éãããããŠããŸããïŒã
0ç¹ïŒå šããªãïŒã 3ç¹ïŒéåžžã«æ¯éãããïŒã§è©äŸ¡ãããDSM-5-TRã®èšºæåºæºBã§ã¯ããèšåºçã«èããèŠçãŸãã¯æ©èœé害ããå¿ èŠã ããããããéèŠãªãã ãPHQ-9ã®ã¹ã³ã¢ãé«ããŠããæ©èœé害ããªããã°ã蚺æã¯æ éã«ãªãã¹ãã ããã
Dr. SAP: ãPHQ-9 Q9ïŒèªæ®ºå¿µæ ®ïŒã«ã€ããŠãããã¯ç¹å¥ãªæ±ããããå¿ èŠããããšèããããšããããŸãã...ã
Dr. MK: ããã®éããQ9ã¯ç¹å¥ãªãã ãããã¯"Point of no returnïŒåž°éäžèœç¹ïŒ"ãé¿ããããã®ãæéèŠé ç®ãªãã ããQ9ã«0ç¹ä»¥å€ã®åçãããã°ãå³åº§ã«è©³çްãªèªæ®ºãªã¹ã¯è©äŸ¡ãå¿ èŠã ãã©ããªã«å¿ãããŠãããããåŸåãã«ããŠã¯ãããªããã
Dr. SAP: ãã¹ã³ã¢ãªã³ã°ã®è§£éã«ã€ããŠãæããŠãã ãããäŸãã°ãã¹ã³ã¢ã15ç¹ã ã£ãããã©ãè§£éããã°ããã§ããïŒã
Dr. MK: ãPHQ-9ã®ã¹ã³ã¢ã¯ãéç床ã®è©äŸ¡ã«ã䜿ãããã ïŒ
0-4ç¹: çç¶ãªããæå°éïŒèšºæåºæºãæºãããªãïŒ
5-9ç¹: 軜çïŒ5-6çç¶ãæå°åºæºïŒ
10-14ç¹: äžççïŒ6-7çç¶ïŒ
15-19ç¹: äžççãéçïŒ7-8çç¶ïŒ
20-27ç¹: éçïŒ8-9çç¶ãã»ãŒå
šãŠïŒ
ã¹ã³ã¢15ç¹ãšããããšã¯ãå¹³åããŠ1é ç®ããã1.67ç¹ïŒãåå以äžã®æ¥ãçšåºŠïŒã ããã7-8çç¶ãäžç床以äžããããšããããšãããã¯äžççãéçã®ãã€ç ãšèããããããã
ââââââââââââââââââââââââââ
ð 3ã¹ããã蚺æããã»ã¹ã®èŠç¹
â ã¹ããã1ïŒ30ç§ïŒ: PHQ-2ã§ã¹ã¯ãªãŒãã³ã°ïŒã¹ã³ã¢â¥2ç¹ã§éœæ§ïŒ
â ã¹ããã2ïŒ3-5åïŒ: PHQ-9å šäœã宿œ â ã¹ã³ã¢å + æ©èœé害確èª
â ã¹ããã3ïŒèšºæç¢ºèªïŒ: DSM-5-TR蚺æåºæºã¯ãPHQ-9ã§ã»ãŒç¢ºèªæžã¿
â PHQ-9 Q9ïŒèªæ®ºå¿µæ ®ïŒã¯ç¹å¥: 0ç¹ä»¥å€ãªãå³åº§ã«è©³çްè©äŸ¡å¿ é ïŒ"Point of no return"ãé¿ããïŒ
â ã¹ã³ã¢è§£é: 5-9ç¹ïŒè»œçïŒã10-14ç¹ïŒäžççïŒã15-19ç¹ïŒäžççãéçïŒã20-27ç¹ïŒéçïŒ
ââââââââââââââââââââââââââ
ð¯ ã»ã¯ã·ã§ã³5: ç·æ¬ïŒã±ãŒã¹ã¹ã¿ãã£ãšTake-home MessageïŒ
Dr. MK: ãããããå®éã®ã±ãŒã¹ã§èããŠã¿ããããã£ãã®æ£è ããã®ããŒã¿ã䜿ã£ãŠã蚺æããã»ã¹ã確èªããŠã¿ããããã
[çäŸæç€º]
35æ³ã女æ§ãäŒç€Ÿå¡
䞻蚎: 2é±éåããæ°åã®èœã¡èŸŒã¿ãä»äºãžã®éäžåäœäž
çŸç æŽ: ä»äºã§ã®å€§ããªãã¹ããã£ããã§ãåŸã ã«æ°åãèœã¡èŸŒãããã«ãªã£ã
PHQ-9ã®çµæ:
Q1ïŒã¢ã³ãããã¢ïŒ: 2ç¹ïŒåå以äžã®æ¥ïŒ
Q2ïŒæãã€æ°åïŒ: 3ç¹ïŒã»ãŒæ¯æ¥ïŒ
Q3ïŒç¡ç ïŒ: 2ç¹ïŒåå以äžã®æ¥ïŒ
Q4ïŒç²åŽïŒ: 2ç¹ïŒåå以äžã®æ¥ïŒ
Q5ïŒé£æ¬²ïŒ: 1ç¹ïŒæ°æ¥ïŒ
Q6ïŒç¡äŸ¡å€æïŒ: 2ç¹ïŒåå以äžã®æ¥ïŒ
Q7ïŒéäžåïŒ: 3ç¹ïŒã»ãŒæ¯æ¥ïŒ
Q8ïŒç²Ÿç¥éåçç¶ïŒ: 0ç¹
Q9ïŒèªæ®ºå¿µæ ®ïŒ: 0ç¹
åèšã¹ã³ã¢: 15ç¹
æ©èœé害: ä»äºã«ãéåžžã«æ¯éããããïŒ3ç¹ïŒ
Dr. SAP: ããŸããã¹ããã1ã®PHQ-2ã§ç¢ºèªãããšãQ1ïŒ2ç¹ïŒ+ Q2ïŒ3ç¹ïŒ= 5ç¹ãªã®ã§ãæããã«éœæ§ã§ãããã¹ããã2ã®PHQ-9ã®çµæãèŠããšãåèš15ç¹ã§äžççãéçã®ãã€ç ãçãããŸããã¹ããã3ã®DSM-5-TR蚺æåºæºã確èªãããš...ã
Dr. MK: ãã©ã確èªããïŒã
Dr. SAP: ãâ æãã€æ°åïŒQ2: 3ç¹ïŒâãâ¡ã¢ã³ãããã¢ïŒQ1: 2ç¹ïŒâãâ¢äžç /éç ïŒQ3: 2ç¹ïŒâãâ£é£æ¬²å€åïŒQ5: 1ç¹ïŒ...ããã¯1ç¹ïŒæ°æ¥ïŒãªã®ã§ãDSM-5-TRã®åºæºâ£ãæºããã埮åŠã§ãããâ€ç²åŽïŒQ4: 2ç¹ïŒâãâŠéäžåäœäžïŒQ7: 3ç¹ïŒâãâ§ç¡äŸ¡å€æïŒQ6: 2ç¹ïŒâãã§åèš7é ç®ã該åœããŸããQ9ïŒèªæ®ºå¿µæ ®ïŒã¯0ç¹ãªã®ã§ãç·æ¥æ§ã¯äœãã§ãããæ©èœé害ããéåžžã«æ¯éãããããšããã®ã§ã蚺æåºæºBãæºãããŸããäºæ¬¡çåå ã確èªããŠã忥µæ§éå®³ã®æ¢åŸããªãããšãè¬å€æ§ã®å¯èœæ§ããªãããšã確èªããã°ã倧ãã€ç æ§é害ã®èšºæã確å®ããŸãããã
Dr. MK: ãå®ç§ã ãïŒ1ã€ã ãè£è¶³ãããšãQ5ïŒé£æ¬²ïŒã1ç¹ïŒæ°æ¥ïŒã ãã©ãäœéå€åã確èªããæ¹ããããããããªãããã§ãããã§ã«7é ç®ã§èšºæåºæºãæºãããŠããã®ã§ãQ5ããªããŠã蚺æã¯å¯èœã ãããšãQ9ã0ç¹ãªã®ã§ãèªæ®ºãªã¹ã¯ã¯äœããšå€æã§ãããã©ãä»åŸã宿çã«ç¢ºèªããå¿ èŠãããããã
Dr. SAP: ãããããŸãããã§ã¯ã蚺æãã€ããããæ²»çã«é²ãããã§ãããã
Dr. MK: ããã®éãã仿¥åŠãã ãã€ã³ããæŽçãããš...ã
ð¯ æ¬æ¥ã®Take-home Message
ââââââââââââââââââââââââââ
1ïžâ£ PHQ-9ã¯DSM-5-TRã®9é ç®ã«1察1察å¿ïŒ"Game-changer"ïŒ
â å®å šå¯Ÿå¿7é ç®ãéšå察å¿2é ç®ïŒäœéå€åã»æ±ºæå°é£ã¯è¿œå 確èªïŒ
â PHQ-9ã宿œããã°ãDSM-5-TRã®èšºæåºæºã¯ã»ãŒç¢ºèªæžã¿
â ã¹ã³ã¢è§£éïŒ5-9ç¹ïŒè»œçïŒã10-14ç¹ïŒäžççïŒã15-19ç¹ïŒäžççãéçïŒã20-27ç¹ïŒéçïŒ
2ïžâ£ PHQ-2ã¯å¿ é çç¶2ã€ã«å¯Ÿå¿ïŒ"Golden rule"ïŒ
â PHQ-2 = â æãã€æ°å + â¡ã¢ã³ãããã¢ïŒDSM-5-TRã®å¿ é çç¶ïŒ
â äž¡æ¹é°æ§ãªã蚺æåºæºãæºãããªã â 30ç§ã§å¹ççã¹ã¯ãªãŒãã³ã°å¯èœ
â ã«ãããªãâ¥2ç¹ã§éœæ§ â PHQ-9ãž
3ïžâ£ 3ã¹ããã蚺æããã»ã¹ã§å¹çå
â ã¹ããã1ïŒ30ç§ïŒ: PHQ-2ã§ã¹ã¯ãªãŒãã³ã°
â ã¹ããã2ïŒ3-5åïŒ: PHQ-9å šäœ + æ©èœé害è©äŸ¡
â ã¹ããã3: DSM-5-TR蚺æåºæºã¯PHQ-9ã§ç¢ºèªæžã¿ + äºæ¬¡çåå é€å€
â PHQ-9 Q9ïŒèªæ®ºå¿µæ ®ïŒã¯"Point of no return"ãé¿ããæéèŠé ç®ïŒ0ç¹ä»¥å€ãªãå³åº§ã«è©³çްè©äŸ¡
ââââââââââââââââââââââââââ
Dr. MK: ãææ¥ããã®èšåºã§ããã®3ã¹ãããã®èšºæããã»ã¹ãæèããŠã¿ãŠãç¹ã«ãPHQ-9ãšDSM-5-TRã®å¯Ÿå¿é¢ä¿ãçè§£ããã°ã蚺æãæ Œæ®µã«å¹çåãããããŸãå°ã£ãããšããã£ããããã€ã§ãçžè«ããŠããã
Dr. SAP: ãããããšãããããŸããïŒPHQ-9ãDSM-5-TRã®èšºæåºæºãšå®å šã«å¯Ÿå¿ããŠãããšããããšãçè§£ã§ããŠã蚺æã®æµãããããã¯ãªã¢ã«ãªããŸãããç¹ã«ãPHQ-2ã®æå³ãããã£ãŠãã¹ã¯ãªãŒãã³ã°ãå¹çåã§ãããã§ããã
ââââââââââââââââââââââââââ
ð åèè³æã»åèæç®
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606-613.
Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010;8(4):348-353.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association, 2022.
Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272(22):1749-1756.
ð¬ ãã®èšäºã«ã€ããŠ
ãã®èšäºã圹ã«ç«ã£ããããã²ã·ã§ã¢ããŠãã ããããŸãããæèŠã»ã質åãããã°ã³ã¡ã³ãæ¬ã§ãæ°è»œã«ã©ããã
ââââââââââââââââââââââââââ